Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05481450 · ClinicalTrials.gov registry record · NA

Efficacy and Safety Safety of Nutritears® in Adults With Dry Eye Syndrome

A NA study, sponsored by Applied Science & Performance Institute.

Completed
Registry status
NA
Development phase
131
Enrollment target

NCT05481450 is a NA study that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 131 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05481450, a NA study, has completed, sponsored by Applied Science & Performance Institute.

COMPLETED
Registry status
NA
Development phase
131 participants
Enrollment target

Study Summary

This is a prospective, randomized, double-blind, parallel, placebo-controlled, clinical interventional study. The purpose of this study is to evaluate the efficacy and safety of Nutritears®, a dietary supplement of OmniActive Health Technologies, in adult subjects with dry eye syndrome (DES). Subjects shall be instructed to consume one capsule of their assigned investigational study product every morning after the breakfast, at the same time every day, for 56 days (8 weeks).

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Blink NutriTears

Trial Details

FieldValue
Enrollment Target 131 participants
Start Date 2022-08-15
Est. Completion 2023-05-22
Phase NA

What the Registry Record Tells You About NCT05481450

The ClinicalTrials.gov registry entry for NCT05481450 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Applied Science & Performance Institute, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT05481450 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05481450 about?

NCT05481450 is a clinical study titled "Efficacy and Safety Safety of Nutritears® in Adults With Dry Eye Syndrome". This is a prospective, randomized, double-blind, parallel, placebo-controlled, clinical interventional study. The purpose of this study is to evaluate the efficacy and safety of Nutritears®, a dietary supplement of OmniActive Health Technologies, in adult subjects with dry eye syndrome (DES). Subjec...

What is the current status of trial NCT05481450?

This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2022-08-15. Estimated completion is 2023-05-22.

What interventions are being tested in trial NCT05481450?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Blink NutriTears (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05481450?

This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.